Latest Breaking News On - Artiva biotherapeutic allo - Page 1 : comparemela.com

Throughout 2023, interest in the application of CAR-T and other cell therapies to autoimmune disease skyrocketed, with a multitude of clinical trials being initiated by various companies.

United statesDavid porterTiffany chenPetera merkelArtiva biotherapeuticsDavidj changArtiva biotherapeutic alloTom van blarcomNkarta incArtiva biotherapeutics incImmpact bio united states incCabaletta bio incGracell biotechnologies incDivision of rheumatologyKyverna therapeuticsCabaletta bio